News

Agios Pharmaceuticals gears up for a pivotal 2025 with key PYRUKYND milestones, including FDA decisions for thalassemia.
Sanofi's SAR446523 gains FDA orphan drug status, offering hope for relapsed multiple myeloma patients with its targeted ...
Artificial Intelligence (AI) continues to revolutionize industries and is poised to bring transformative change in healthcare delivery, ...
In a breakthrough for cardiovascular medicine, researchers have harnessed artificial intelligence to discover unexpected ...
Eli Lilly's diabetes drug Mounjaro demonstrated superior efficacy to its predecessor Trulicity in reducing heart attack and ...
The wearable, noninvasive CardioTag is designed to capture electrocardiogram, photoplethysmogram, and seismocardiogram signals, as well as heart rate and pulse rate.
A new technology that harnesses artificial intelligence (AI) to analyze mammograms and improve the accuracy of predicting a ...
Dr. Vinay Prasad, the chief scientific officer at the Food and Drug Administration, has resigned after only three months in ...
A new technology that harnesses AI to analyze mammograms and improve the accuracy of predicting a woman's personalized ...
Dr. Vinay Prasad, a vocal critic of the FDA before joining its ranks, has stepped down from his leadership post at the agency ...
Cardiosense, a medical AI company transforming cardiovascular disease management, today announced that the U.S. Food and Drug ...
Researchers integrated machine learning with multi-tiered validation to identify FDA-approved non-lipid-lowering drugs with lipid-modifying potential. From 3,430 drugs screened, 29 candidates emerged.